OCC[C@@H]1C[C@H](O)[C@@H](O)[C@@]2(OCc3ccc(CO)cc32)O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?